Chloromycetin: Potent Broad-Spectrum Antibiotic Therapy
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.00 (0%) | 🛒 Add to cart |
| 90 | $0.79 | $78.00 $71.00 (9%) | 🛒 Add to cart |
| 120 | $0.76 | $104.00 $91.00 (12%) | 🛒 Add to cart |
| 270 | $0.69 | $234.00 $185.00 (21%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $312.00 $242.00 (22%) | 🛒 Add to cart |
Similar products
Chloromycetin (chloramphenicol) is a bacteriostatic antibiotic with a well-established history in clinical practice, valued for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria, as well as certain other microorganisms. It functions by inhibiting bacterial protein synthesis, binding to the 50S ribosomal subunit, thereby preventing peptide bond formation. While its systemic use is now reserved for serious infections due to potential hematologic toxicity, its topical and ophthalmic formulations remain widely utilized for targeted antimicrobial action. This agent represents a critical tool in specific therapeutic scenarios where other antibiotics may be ineffective or contraindicated.
Features
- Active ingredient: Chloramphenicol
- Available forms: Oral capsules, topical cream/ointment, ophthalmic solution/ointment, intravenous injection (restricted use)
- Mechanism: Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit
- Spectrum: Broad-spectrum activity against many aerobic and anaerobic bacteria, Rickettsia, and some Chlamydia species
- Stability: Chemically stable in various formulations; requires protection from light in some preparations
Benefits
- Effective against a wide range of pathogens, including multidrug-resistant organisms in certain cases
- Excellent tissue penetration, including central nervous system and ocular tissues
- Rapid bacteriostatic action, helping to control infection progression quickly
- Multiple administration routes allow for targeted therapy based on infection site
- Cost-effective option for specific indications where newer alternatives are prohibitively expensive
- Well-established efficacy profile with decades of clinical use and research
Common use
Chloromycetin is primarily indicated for serious infections when less potentially toxic alternatives are contraindicated or ineffective. Systemic administration is reserved for life-threatening conditions such as bacterial meningitis, typhoid fever, and other severe Salmonella infections. Topical formulations are commonly used for superficial skin infections, burn wound prophylaxis, and ocular infections including bacterial conjunctivitis. The ophthalmic preparation is particularly valuable for treating eye infections caused by susceptible organisms. In veterinary medicine, it remains an important antibiotic for various animal infections. Its use requires careful consideration of risk-benefit ratio due to potential adverse effects.
Dosage and direction
Dosage varies significantly based on formulation, infection severity, patient age, and renal/hepatic function. For systemic administration in adults: 50-100 mg/kg/day divided every 6 hours, not exceeding 4 g daily. Pediatric dosing requires careful calculation based on weight and close monitoring. Topical formulations: Apply thin layer to affected area 1-3 times daily. Ophthalmic solution: 1-2 drops in affected eye(s) every 3-6 hours; ointment: Apply small amount in conjunctival sac every 3-6 hours. Duration of treatment should be the shortest possible to achieve clinical cure, typically 7-14 days for most infections. Always complete the full course as prescribed, even if symptoms improve earlier.
Precautions
Regular monitoring of complete blood counts is essential during systemic therapy due to risk of bone marrow suppression. Use with caution in patients with hepatic or renal impairment, requiring dosage adjustment. Avoid unnecessary use to prevent development of bacterial resistance. Pregnancy Category C: Use only if potential benefit justifies potential risk to fetus. Nursing mothers should avoid breastfeeding during treatment as chloramphenicol excretes in breast milk. Topical use on large areas or prolonged application should be avoided to prevent systemic absorption. Patients should be advised to report any signs of infection worsening or unusual bleeding/bruising immediately.
Contraindications
Hypersensitivity to chloramphenicol or any component of the formulation. History of chloramphenicol-induced blood dyscrasias. Avoid concurrent use with other drugs that cause bone marrow suppression. Not recommended for prophylaxis of bacterial infections or treatment of minor infections. Contraindicated in infants under 2 years for systemic administration (gray baby syndrome risk). Avoid in patients with pre-existing bone marrow depression or hematologic disorders. The ophthalmic formulation is contraindicated in viral, fungal, or mycobacterial eye infections without concomitant appropriate therapy.
Possible side effect
Hematologic: Bone marrow suppression (dose-related and reversible), aplastic anemia (idiosyncratic and often fatal), granulocytopenia, thrombocytopenia Gastrointestinal: Nausea, vomiting, diarrhea, glossitis, stomatitis Neurological: Optic neuritis, peripheral neuropathy (especially with prolonged use) Other: Gray baby syndrome in neonates, hypersensitivity reactions, superinfections, Jarisch-Herxheimer reaction in syphilis treatment Topical: Local irritation, burning sensation, allergic contact dermatitis Ophthalmic: Temporary blurred vision, burning/stinging upon instillation
Drug interaction
Warfarin: Enhanced anticoagulant effect requiring INR monitoring Phenytoin: Increased phenytoin levels and potential toxicity Sulfonylureas: Enhanced hypoglycemic effect Cyclophosphamide: Enhanced bone marrow suppression Rifampin: Reduced chloramphenicol levels through enhanced metabolism Paracetamol: Potential increased risk of toxicity Vitamin B12: Interferes with hematinic response Barbiturates: Reduced chloramphenicol efficacy Oral contraceptives: Possible reduced contraceptive efficacy
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed administration. For topical or ophthalmic formulations, apply the missed dose when remembered, then continue with regular schedule. Maintaining consistent antibiotic levels is important for therapeutic efficacy, so patients should strive for regular dosing intervals. If multiple doses are missed, contact the prescribing healthcare provider for guidance.
Overdose
Systemic overdose can cause serious complications including cardiovascular collapse (gray syndrome in infants), bone marrow suppression, nausea, vomiting, and acidosis. Symptoms may include pale skin, vomiting, irregular breathing, abdominal distension, and hypothermia. Treatment is primarily supportive with gastric lavage if recent ingestion, activated charcoal, and meticulous supportive care including monitoring of blood counts and vital signs. Hemodialysis is not effective for removal. There is no specific antidote. Topical overdose is unlikely to cause systemic effects unless applied to extensive areas or compromised skin barriers.
Storage
Store at controlled room temperature (15-30°C or 59-86°F). Protect from light and moisture. Keep containers tightly closed. Do not freeze liquid formulations. Oral capsules and topical preparations should be kept in their original containers. Ophthalmic solutions typically have a 28-day expiration after opening—discard after this period even if medication remains. Keep all medications out of reach of children and pets. Do not use if discolored or containing particulate matter. Proper disposal of unused medication is essential to prevent accidental ingestion or environmental contamination.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Chloromycetin is a prescription medication that should be used only under the supervision of a qualified healthcare professional. The prescribing physician will determine the appropriate dosage and duration based on individual patient factors. Patients should not self-medicate or adjust dosage without medical consultation. While every effort has been made to ensure accuracy, healthcare providers should verify information with current prescribing literature before making treatment decisions.
Reviews
“Chloromycetin remains our go-to option for multidrug-resistant Salmonella infections in the ICU setting. While we monitor blood counts rigorously, its efficacy in critical cases is unmatched when other options fail.” - Infectious Disease Specialist, 15 years experience
“The ophthalmic solution has excellent coverage for common conjunctivitis pathogens. I appreciate its stability and patient tolerance, though I reserve it for confirmed bacterial cases to prevent resistance.” - Ophthalmologist, 8 years experience
“While systemic use requires extreme caution, topical chloramphenicol is invaluable in burn wound management. Its broad spectrum and penetration help prevent sepsis in high-risk patients.” - Burn Unit Director, 22 years experience
“Proper patient education about the hematologic risks is crucial. When used appropriately with monitoring, it can be lifesaving in specific scenarios where treatment options are limited.” - Clinical Pharmacist, 12 years experience